annb0t
Top 20
Haemonetics Corporation HAE delivered third-quarter fiscal 2025 adjusted earnings per share (EPS) of $1.19, which rose 14.4% year over year. The bottom line was on par with the Zacks Consensus Estimate.
Find the latest EPS estimates and surprises on Zacks Earnings Calendar.
On a GAAP basis, EPS was 74 cents compared with 61 cents in the prior-year quarter.
Following the earnings announcement, shares of HAE rose 0.02% in after-market trading yesterday.
HAEâs Q3 Revenues
Revenues increas...
>>> Read more: HAE Q3 Earnings In Line, '25 Sales View Cut, Stock Up in Aftermarket
Find the latest EPS estimates and surprises on Zacks Earnings Calendar.
On a GAAP basis, EPS was 74 cents compared with 61 cents in the prior-year quarter.
Following the earnings announcement, shares of HAE rose 0.02% in after-market trading yesterday.
HAEâs Q3 Revenues
Revenues increas...
>>> Read more: HAE Q3 Earnings In Line, '25 Sales View Cut, Stock Up in Aftermarket
